Barclays Maintains an 'Overweight' on Mattress Firm Holding (MFRM); Adjusting Estimates After Q2 Review

Go back to Barclays Maintains an 'Overweight' on Mattress Firm Holding (MFRM); Adjusting Estimates After Q2 Review

Mattress Firm (MFRM) Tops Q2 EPS by 2c; Boosts FY12 Outlook; to Acquire Mattress XPress

September 6, 2012 4:03 PM EDT

Mattress Firm (NASDAQ: MFRM) reported Q2 EPS of $0.30, $0.02 better than the analyst estimate of $0.28. Revenue for the quarter came in at $262 million versus the consensus estimate of $264.52 million.

Mattress Firm sees FY2012 EPS of $1.67-1.73, versus prior guidance of $1.65-1.71 and the consensus of $1.49. Mattress Firm sees... More